Rhabdomyosarcoma (RMS) is a rare childhood cancer. Dr Tischkowitz wants to find out which genes make children more likely to develop it. Knowing this will help us to identify children who have this cancer earlier, and begin possibly life-saving treatment sooner.
This project is looking at RMS, and genetic factors that mean certain children are more likely to get it. If we can learn this, we may be able to treat and cure more of them.
Investigating microRNA processing genes in rhabdomyosarcomas and other DICER1-related childhood tumours
Dr Marc Tischkowitz
Academic Laboratory of Medical Genetics, University of Cambridge
Cambridge, CB2 0QQ
1 October 2016